Literature DB >> 26880333

The Densely O-Glycosylated MUC2 Mucin Protects the Intestine and Provides Food for the Commensal Bacteria.

Liisa Arike1, Gunnar C Hansson2.   

Abstract

All mucins are highly O-glycosylated by variable glycans depending on species, histoblood group and organ. This makes the intestinal main mucin MUC2 non-degradable by the host digestive system but well by both commensal and pathogenic bacteria. The MUC2 glycans are important for selection of the commensal bacteria and act as a nutritional source for the bacteria; this also helps the host to recover some of the energy spent on constantly renewing the protective mucus layer. Glycosylation is the most diverse and common posttranslational modification of cell surfaces and secreted proteins. N-Glycosylation is most well studied and predictable, whereas O-glycosylation is more diverse and less well understood. O-Glycosylation is also often called mucin-type glycosylation as it is typical for mucins that often have more than 80% of the mass as O-glycans. This review will discuss the mucin-type O-glycosylation and especially the O-glycosylation of human and mice intestinal mucin MUC2 in relation to bacteria and disease.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  colon; glycosylation; glycosyltransferase; mucus; small intestine

Mesh:

Substances:

Year:  2016        PMID: 26880333      PMCID: PMC4982847          DOI: 10.1016/j.jmb.2016.02.010

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  76 in total

1.  Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways.

Authors:  Ana Magalhães; Ricardo Marcos-Pinto; Alison V Nairn; Mitche Dela Rosa; Rui M Ferreira; Susana Junqueira-Neto; Daniela Freitas; Joana Gomes; Patrícia Oliveira; Marta R Santos; Nuno T Marcos; Wen Xiaogang; Céu Figueiredo; Carla Oliveira; Mário Dinis-Ribeiro; Fátima Carneiro; Kelley W Moremen; Leonor David; Celso A Reis
Journal:  Biochim Biophys Acta       Date:  2015-07-02

2.  A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism.

Authors:  Buck S Samuel; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-16       Impact factor: 11.205

3.  Sd(a)-antigen-like structures carried on core 3 are prominent features of glycans from the mucin of normal human descending colon.

Authors:  C Capon; E Maes; J C Michalski; H Leffler; Y S Kim
Journal:  Biochem J       Date:  2001-09-15       Impact factor: 3.857

4.  Calcium and pH-dependent packing and release of the gel-forming MUC2 mucin.

Authors:  Daniel Ambort; Malin E V Johansson; Jenny K Gustafsson; Harriet E Nilsson; Anna Ermund; Bengt R Johansson; Philip J B Koeck; Hans Hebert; Gunnar C Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

5.  Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.

Authors:  Benjamin L Schulz; Andrew J Sloane; Leanne J Robinson; Lucille T Sebastian; Allan R Glanville; Yuanlin Song; Alan S Verkman; Jenny L Harry; Nicolle H Packer; Niclas G Karlsson
Journal:  Biochem J       Date:  2005-05-01       Impact factor: 3.857

6.  Unfolding dynamics of the mucin SEA domain probed by force spectroscopy suggest that it acts as a cell-protective device.

Authors:  Thaher Pelaseyed; Michael Zäch; Asa C Petersson; Frida Svensson; Denny G A Johansson; Gunnar C Hansson
Journal:  FEBS J       Date:  2013-02-21       Impact factor: 5.542

7.  Gel-forming mucins appeared early in metazoan evolution.

Authors:  Tiange Lang; Gunnar C Hansson; Tore Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-02       Impact factor: 11.205

8.  Evidence of regio-specific glycosylation in human intestinal mucins: presence of an acidic gradient along the intestinal tract.

Authors:  Catherine Robbe; Calliope Capon; Emmanuel Maes; Monique Rousset; Alain Zweibaum; Jean-Pierre Zanetta; Jean-Claude Michalski
Journal:  J Biol Chem       Date:  2003-09-02       Impact factor: 5.157

9.  Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans.

Authors:  Guangyu An; Bo Wei; Baoyun Xia; J Michael McDaniel; Tongzhong Ju; Richard D Cummings; Jonathan Braun; Lijun Xia
Journal:  J Exp Med       Date:  2007-05-21       Impact factor: 14.307

10.  Membrane protein profiling of human colon reveals distinct regional differences.

Authors:  Sjoerd van der Post; Gunnar C Hansson
Journal:  Mol Cell Proteomics       Date:  2014-06-02       Impact factor: 5.911

View more
  46 in total

Review 1.  Frontline defenders: goblet cell mediators dictate host-microbe interactions in the intestinal tract during health and disease.

Authors:  Joannie M Allaire; Vijay Morampudi; Shauna M Crowley; Martin Stahl; Hongbing Yu; Kirandeep Bhullar; Leigh A Knodler; Brian Bressler; Kevan Jacobson; Bruce A Vallance
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-11-09       Impact factor: 4.052

2.  Loss of the mucosal barrier alters the progenitor cell niche via Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling.

Authors:  Liping Zhang; Bradley Turner; Katharina Ribbeck; Kelly G Ten Hagen
Journal:  J Biol Chem       Date:  2017-11-10       Impact factor: 5.157

3.  Increased Listeria monocytogenes Dissemination and Altered Population Dynamics in Muc2-Deficient Mice.

Authors:  Ting Zhang; Jumpei Sasabe; Karthik Hullahalli; Brandon Sit; Matthew K Waldor
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 4.  Mechanisms and consequences of intestinal dysbiosis.

Authors:  G Adrienne Weiss; Thierry Hennet
Journal:  Cell Mol Life Sci       Date:  2017-03-28       Impact factor: 9.261

Review 5.  Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome.

Authors:  Yonghyun Lee; Nobuhiko Kamada; James J Moon
Journal:  Adv Drug Deliv Rev       Date:  2021-10-26       Impact factor: 15.470

6.  Mucin-Type O-GalNAc Glycosylation in Health and Disease.

Authors:  Ieva Bagdonaite; Emil M H Pallesen; Mathias I Nielsen; Eric P Bennett; Hans H Wandall
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

7.  Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer.

Authors:  Melinda A Engevik; Amy C Engevik; Kristen A Engevik; Jennifer M Auchtung; Alexandra L Chang-Graham; Wenly Ruan; Ruth Ann Luna; Joseph M Hyser; Jennifer K Spinler; James Versalovic
Journal:  ACS Infect Dis       Date:  2020-11-11       Impact factor: 5.084

8.  An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function.

Authors:  Elisabeth E L Nyström; Beatriz Martinez-Abad; Liisa Arike; George M H Birchenough; Eric B Nonnecke; Patricia A Castillo; Frida Svensson; Charles L Bevins; Gunnar C Hansson; Malin E V Johansson
Journal:  Science       Date:  2021-04-16       Impact factor: 63.714

9.  Clostridium butyricum Induces the Production and Glycosylation of Mucins in HT-29 Cells.

Authors:  Qi Lili; Lu Xiaohui; Mao Haiguang; Wang Jinbo
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 6.073

Review 10.  "Driver-passenger" bacteria and their metabolites in the pathogenesis of colorectal cancer.

Authors:  Marion Avril; R William DePaolo
Journal:  Gut Microbes       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.